Microalgae and cyanobacteria represent a formidable source of metabolites: some are toxic, but many others have potential beneficial applications and are attracting a lot of interest from different industrial sectors (food, drugs, cosmetics) seeking for innovative, active and “natural” products. Microalgae biomass represents a rich source for discovery. The potential for algae-based ingredients in the industry relies on the manipulation and targeting of ingredients to fit increasingly niche product specifications. Microalgae are exposed to extreme environment and thus have developed unique mechanism for protection. Furthermore, these organisms produce different metabolites which we need to identify and exploit in a sustainable way for the production of food, drugs and cosmetics. The AlgaeCeuticals project (Project N. 778263, H2020-MSCA-RISE-2017) will take advantage of the native microalgae and cyanobacteria strains producing high added value products and through the application of novel omics technologies (genomics, metagenomics, transcriptomics, proteomics, enzymomics and metabolomics) as well as algae culture technologies and production of novel products. AlgaeCeuticals will screen and characterize microalgal biodiversity, develop and optimize algae culture systems, develop omics resources for algae and also develop downstream processing strategies and novel products. For this reason and in order to achieve its object, 4 academic and research centers from Greece (Centre for Research and Technology Hellas; Agricultural University of Athens), Italy (Fondazione Edmund Mach) and Spain (Centro Tecnológico Nacional de la Conserva y Alimentación) will collaborate for four years with 3 industrial R&D partners from Greece (Fresh Formula), Spain (Bionos Biotech ND) and Austria (Ecoduna AG). Through this collaboration the academic partners will work closely with the industrial R&D and form a complementary and highly competitive team that will promote transfer of knowledge and excellence to industrial partners. This will strengthen the industrial competitiveness in the field of food and cosmetics in the process of the design, development, testing of the products proposed by the project.

Madesis, P.; Labrou, N.; Cerasino, L.; Salmaso, N.; Palmieri, L.; Martens, S.; Fluch, S.; Ruiz, P.F.; San Martin, A.M.; Mullor, J.; Bakoula, E.; Chatzikonstantinou, M. (2018). Exploitation of the biotechnological potential of microalgae: the AlgaeCeuticals project. In: The 18th International Conference on Harmful Algae (ICHA 2018): from ecosystems to socio-ecosystems, Nantes, France, 21-26 October 2018. Nantes: 582. url: https://www.icha2018.com/medias/content/files/ICHA_2018_Abstract_Book_v7.pdf handle: http://hdl.handle.net/10449/51166

Exploitation of the biotechnological potential of microalgae: the AlgaeCeuticals project

Cerasino, L.
;
Salmaso, N.;Palmieri, L.;Martens, S.;
2018-01-01

Abstract

Microalgae and cyanobacteria represent a formidable source of metabolites: some are toxic, but many others have potential beneficial applications and are attracting a lot of interest from different industrial sectors (food, drugs, cosmetics) seeking for innovative, active and “natural” products. Microalgae biomass represents a rich source for discovery. The potential for algae-based ingredients in the industry relies on the manipulation and targeting of ingredients to fit increasingly niche product specifications. Microalgae are exposed to extreme environment and thus have developed unique mechanism for protection. Furthermore, these organisms produce different metabolites which we need to identify and exploit in a sustainable way for the production of food, drugs and cosmetics. The AlgaeCeuticals project (Project N. 778263, H2020-MSCA-RISE-2017) will take advantage of the native microalgae and cyanobacteria strains producing high added value products and through the application of novel omics technologies (genomics, metagenomics, transcriptomics, proteomics, enzymomics and metabolomics) as well as algae culture technologies and production of novel products. AlgaeCeuticals will screen and characterize microalgal biodiversity, develop and optimize algae culture systems, develop omics resources for algae and also develop downstream processing strategies and novel products. For this reason and in order to achieve its object, 4 academic and research centers from Greece (Centre for Research and Technology Hellas; Agricultural University of Athens), Italy (Fondazione Edmund Mach) and Spain (Centro Tecnológico Nacional de la Conserva y Alimentación) will collaborate for four years with 3 industrial R&D partners from Greece (Fresh Formula), Spain (Bionos Biotech ND) and Austria (Ecoduna AG). Through this collaboration the academic partners will work closely with the industrial R&D and form a complementary and highly competitive team that will promote transfer of knowledge and excellence to industrial partners. This will strengthen the industrial competitiveness in the field of food and cosmetics in the process of the design, development, testing of the products proposed by the project.
Microalgae
Biotechnology
Natural products
2018
Madesis, P.; Labrou, N.; Cerasino, L.; Salmaso, N.; Palmieri, L.; Martens, S.; Fluch, S.; Ruiz, P.F.; San Martin, A.M.; Mullor, J.; Bakoula, E.; Chatzikonstantinou, M. (2018). Exploitation of the biotechnological potential of microalgae: the AlgaeCeuticals project. In: The 18th International Conference on Harmful Algae (ICHA 2018): from ecosystems to socio-ecosystems, Nantes, France, 21-26 October 2018. Nantes: 582. url: https://www.icha2018.com/medias/content/files/ICHA_2018_Abstract_Book_v7.pdf handle: http://hdl.handle.net/10449/51166
File in questo prodotto:
File Dimensione Formato  
Madesis_etal_2018_ICHA-Nantes_Exploitation of the biotechnological potential of microalgae_ the AlgaeCeuticals project.pdf

accesso aperto

Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 1.32 MB
Formato Adobe PDF
1.32 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10449/51166
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact